News Highlights
To Help Recover Balance, Robotic Exoskeletons Have to be Faster Than Human Reflexes
Human balance is a complicated dance, and even the most advanced robots and wearables like robotic exoskeletons have trouble replicating how our brains and bodies work together to keep us upright. A new study from researchers at the Georgia Institute of Technology and Emory University is taking the first step toward addressing the balance problem.
Researchers use Table Tennis to Understand Human-Robot Dynamics in Agile Environments
A team of researchers, led by Matthew Gombolay, an assistant professor in the School of Interactive Computing and director of the Cognitive Optimization and Relational (CORE) Robotics Lab at Georgia Tech, are using the sport of table tennis to showcase that humans may not always trust a robot's explanation of its intended action.
They have developed what is called a "cobot," which uses table tennis to demonstrate the potential areas a robot can work closely with human partners to complete tasks.
(text and background only visible when logged in)
(text and background only visible when logged in)
IRIM Overview
(text and background only visible when logged in)
Robotics Research
The depth and breadth of IRIM breaks through disciplinary boundaries and allows for transformative research that transitions from theory to robustly deployed systems featuring next-generation robots. Fundamental research includes expertise in mechanics, control, perception, artificial intelligence and cognition, interaction, and systems.
Robotics Education
Georgia Tech offers an interdisciplinary path to an M.S. and Ph.D. in Robotics to students enrolled in a participating school within either the Colleges of Computing or Engineering. A fully integrated, multidisciplinary experience, the M.S. & Ph.D. programs include both coursework and research with faculty members in various units across campus.
Core Research Facilities
The Institute for Robotics and Intelligent Machines at Georgia Tech supports and facilitates the operation of several core research facilities on campus allowing our faculty, students and collaborators to advance the boundaries of robotics research.
IRIM & Industry
Our Industry Affiliates Program allows members to explore opportunities for research collaboration, facilities and services, consulting, student hiring, and other interactions. Whether you join as a strategic partner, an affiliate, or as a member of one of our customized consortia, your company will be supported through our work as a interdisciplinary group of robotics leaders.
IRIM & Outreach
The Institute for Robotics & Intelligent Machines (IRIM) participates in numerous K-12 STEM and community outreach activities related to robotics. Additionally, IRIM hosts tours throughout the year, and our student group, RoboGrads, participates in activities to raise awareness of the importance of robotics technology and stimulate interest in the field
New Faculty Spotlight
Alex Abramson - Assistant Professor, School of Chemical and Biomolecular Engineering
Alex Abramson is an assistant professor in the School of Chemical and Biomolecular Engineering at Georgia Tech. His research, which focuses on drug delivery and bioelectronic therapeutics, has been featured in news outlets such as The New York Times, NPR, and Wired. Abramson has received several recognitions for scientific innovation, including being named a member of the Forbes 30 Under 30 Science List and the MIT Technology Review Innovators Under 35 List. He is passionate about translating scientific endeavors from bench to bedside. Large pharmaceutical companies have exclusively licensed a portfolio of his patents to bring into clinical trials, and Abramson serves as a scientific advisor overseeing their commercialization. In addition to his scientific endeavors, Abramson plays an active role in his community by leading Diversity Equity and Inclusion efforts on campus and volunteering as a STEM tutor to local students.
The Abramson Lab builds millimeter-scale robotic devices with applications in medicine, including drug delivery systems, biosensors, and preclinical drug screening tools. The ingestible, implantable, and wearable technologies they create hold profound implications in treating chronic diseases such as diabetes, cancer, and heart failure. The team builds devices with clinical translation in mind, and many of their technologies are now in human trials. From a painless pill capable of replacing burdensome insulin and vaccine injections to a wearable sensor capable of measuring the real-time effects of cancer therapies, The Abramson Lab is constantly pursuing the goal of improving the quality of life for patients worldwide.
(text and background only visible when logged in)
